NUP133
Nuclear pore complex protein Nup133
Also known as: FLJ10814, NU133_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8WUM0
- Gene
- NUP133
- Ensembl
- ENSG00000069248
- Chromosome
- 1
- Canonical length
- 1156 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters
- Subcellular location
- Nuclear membrane
OverviewNCBI Gene
The nuclear envelope creates distinct nuclear and cytoplasmic compartments in eukaryotic cells. It consists of two concentric membranes perforated by nuclear pores, large protein complexes that form aqueous channels to regulate the flow of macromolecules between the nucleus and the cytoplasm. These complexes are composed of at least 100 different polypeptide subunits, many of which belong to the nucleoporin family. The nucleoporin protein encoded by this gene displays evolutionarily conserved interactions with other nucleoporins. This protein, which localizes to both sides of the nuclear pore complex at interphase, remains associated with the complex during mitosis and is targeted at early stages to the reforming nuclear envelope. This protein also localizes to kinetochores of mitotic cells. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1156 residues, UniProt reviewed canonical sequence.
>Q8WUM0|NUP133
1 MFPAAPSPRT PGTGSRRGPL AGLGPGSTPR TASRKGLPLG SAVSSPVLFS PVGRRSSLSS
61 RGTPTRMFPH HSITESVNYD VKTFGSSLPV KVMEALTLAE VDDQLTINID EGGWACLVCK
121 EKLIIWKIAL SPITKLSVCK ELQLPPSDFH WSADLVALSY SSPSGEAHST QAVAVMVATR
181 EGSIRYWPSL AGEDTYTEAF VDSGGDKTYS FLTAVQGGSF ILSSSGSQLI RLIPESSGKI
241 HQHILPQGQG MLSGIGRKVS SLFGILSPSS DLTLSSVLWD RERSSFYSLT SSNISKWELD
301 DSSEKHAYSW DINRALKENI TDAIWGSESN YEAIKEGVNI RYLDLKQNCD GLVILAAAWH
361 SADNPCLIYY SLITIEDNGC QMSDAVTVEV TQYNPPFQSE DLILCQLTVP NFSNQTAYLY
421 NESAVYVCST GTGKFSLPQE KIVFNAQGDS VLGAGACGGV PIIFSRNSGL VSITSRENVS
481 ILAEDLEGSL ASSVAGPNSE SMIFETTTKN ETIAQEDKIK LLKAAFLQYC RKDLGHAQMV
541 VDELFSSHSD LDSDSELDRA VTQISVDLMD DYPASDPRWA ESVPEEAPGF SNTSLIILHQ
601 LEDKMKAHSF LMDFIHQVGL FGRLGSFPVR GTPMATRLLL CEHAEKLSAA IVLKNHHSRL
661 SDLVNTAILI ALNKREYEIP SNLTPADVFF REVSQVDTIC ECLLEHEEQV LRDAPMDSIE
721 WAEVVINVNN ILKDMLQAAS HYRQNRNSLY RREESLEKEP EYVPWTATSG PGGIRTVIIR
781 QHEIVLKVAY PQADSNLRNI VTEQLVALID CFLDGYVSQL KSVDKSSNRE RYDNLEMEYL
841 QKRSDLLSPL LSLGQYLWAA SLAEKYCDFD ILVQMCEQTD NQSRLQRYMT QFADQNFSDF
901 LFRWYLEKGK RGKLLSQPIS QHGQLANFLQ AHEHLSWLHE INSQELEKAH ATLLGLANME
961 TRYFAKKKTL LGLSKLAALA SDFSEDMLQE KIEEMAEQER FLLHQETLPE QLLAEKQLNL
1021 SAMPVLTAPQ LIGLYICEEN RRANEYDFKK ALDLLEYIDE EEDININDLK LEILCKALQR
1081 DNWSSSDGKD DPIEVSKDSI FVKILQKLLK DGIQLSEYLP EVKDLLQADQ LGSLKSNPYF
1141 EFVLKANYEY YVQGQILocalizationUniProt · AlphaFold · HPA
Whether an antibody against NUP133 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 18 nTPM
Expression across tissuesHPA
Tissue
- retina: 18 nTPM
- skeletal muscle: 17 nTPM
- parathyroid gland: 17 nTPM
- thymus: 16 nTPM
- breast: 15 nTPM
- cerebellum: 14 nTPM
Single-cell type
- myonuclei: 99 nCPM
- adrenal medulla cells: 85 nCPM
- oligodendrocytes: 77 nCPM
- sertoli cells: 71 nCPM
- somatotrophs: 69 nCPM
- lactotrophs: 68 nCPM
Immune cell
- non-classical monocyte: 10 nTPM
- myeloid DC: 7.1 nTPM
- MAIT T-cell: 7 nTPM
- naive CD8 T-cell: 6.3 nTPM
- memory CD8 T-cell: 6.2 nTPM
- memory CD4 T-cell: 5.9 nTPM
Brain region
- white matter: 29 nTPM
- cerebellum: 27 nTPM
- basal ganglia: 22 nTPM
- spinal cord: 21 nTPM
- cerebral cortex: 20 nTPM
- medulla oblongata: 20 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NUP133.
Disease | AllUniProt
Conditions NUP133 is implicated in, by any mechanism.
- Nephrotic syndrome 18 (NPHS18) MIM:618177
- Galloway-Mowat syndrome 8 (GAMOS8) MIM:618349
Disease | GeneticClinVar
8 pathogenic / likely-pathogenic of 416 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Nephrotic syndrome, type 18
- Galloway-Mowat syndrome 8
- Autosomal recessive NUP133-related disorders
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.45
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.02
- DepMap mean gene effect
- -1.5
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 14% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- mRNA export from nucleus
- nephron development
- neural tube development
- neurogenesis
- nuclear pore organization
- nucleocytoplasmic transport
- paraxial mesoderm development
- poly(A)+ mRNA export from nucleus
- protein import into nucleus
- somite development
- transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Nucleoporin, Nup133/Nup155-like, C-terminal
- WD40/YVTN repeat-like-containing domain superfamily
- Non-repetitive/WGA-negative nucleoporin C-terminal
- Nuclear pore complex protein Nup133-like
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NUP133 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NUP133 as an antibody target. Whether an autoantibody or antibody against NUP133 could matter depends on whether native NUP133 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NUP133 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NUP133 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...